Compiled all in one place, read news articles from each of the news categories, about drugs, the pharmaceutical industry, national and international awareness causes, scientific meetings, trending stories and epgonline.org headlines.

Site News

Added 9 days ago Drug news

Data for Exparel results in high rates of early discharge and patient satisfaction for total knee or hip arthroplasty

Pacira Pharmaceuticals, Inc. announced new data showing that a patient-optimizing, opioid-sparing enhanced recovery after surgery (ERAS) pathway, which includes intraoperative...

Added 8 days ago Drug news

FDA approves Dupixent to treat adolescents with atopic dermatitis

The FDA has approved Dupixent (dupilumab) for adolescent patients 12 to 17 years of age with moderate-to-severe atopic dermatitis whose...

Added 45 minutes ago Drug news

FDA issues Complete Response Letter for Zynquista to treat type 1 diabetes.- Sanofi + Lexicon

The FDA has issued a Complete Response Letter (CRL) regarding the New Drug Application for investigational Zynquista (sotagliflozin), a dual...

Added 45 minutes ago Drug news

Oral semaglutide 7 mg and 14 mg demonstrated superior HbA1c and body weight reductions compared to Januvia in patients with type 2 diabetes.

Oral semaglutide 7 mg and 14 mg demonstrated superior HbA1c and body weight reductions compared to Januvia (sitagliptin 100 mg)...

Added 45 minutes ago Drug news

FDA issues Complete Response Letter to Recro Pharma relating to IV meloxicam and treatment of moderate to severe pain.

Recro Pharma, Inc. announced it has received a second Complete Response Letter (CRL) from the FDA Office of Drug Evaluation...

Added 1 day ago Drug news

Phase III extension study Recorlev meets objectives in Cushing’s syndrome.- Strongbridge Biopharma

Strongbridge Biopharma announced the top-line findings from the extended evaluation phase of the pivotal Phase III SONICS study of Recorlev...

Added 1 day ago Drug news

Phase III (Clarity AD/Study 301) of BAN 2401 is initiated for early Alzheimer's disease. Eisai + Biogen.

Eisai Co., Ltd. announced that a global Phase III clinical study (Clarity AD/Study 301) of BAN 2401, an anti-amyloid beta...

Added 1 day ago Drug news

BD statement on FDA relating to paclitaxel-coated devices and long term mortality.- Becton, Dickinson and Company

BD (Becton, Dickinson and Company) issued the following statement related to the recent letter from FDA to health care providers...

Added 2 days ago Drug news

FDA requires partial hold on trials for Venclexta

AbbVie has announced the FDA has placed a partial clinical hold on all clinical trials evaluating venetoclax (Venclexta /Venclyxto) for...

Added 2 days ago Drug news

FDA approves Sunosi to improve wakefulness in adult patients

Jazz Pharmaceuticals plc announced that the FDA approved Sunosi (solriamfetol) to improve wakefulness in adult patients with excessive daytime sleepiness...

Search all news articles